This is the authors' abstract. We don't add key points for this paper.
123-I Ioflupane (Datscan®) presynaptic imaging has been shown to have a significant utility in the assessment of patients with movement disorders 123-I Ioflupane SPECT is able to distinguish between Parkinson’s disease (PD) and other forms of parkinsonism without degeneration of the nigrostriatal pathway, including a common movement disorder such as essential tremor, and to assess disease progression in PD and other neurodegenerative disorders involving the substantia nigra.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Castrejón et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: